Toggle navigation
Home
Search
Services
Blog
Contact
About
In Vitro Antineoplastic Drug
Murphy, Martin J.
Hipple Cancer Research Corporation, Dayton, OH, United States
Search 58 grants from Martin Murphy
Search grants from Hipple Cancer Research Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Regulation of cell polarity during neurulation
Neuroimaging of Attentional Control in FTD
Neural Correlates of Emotional Learning and Behavior
Oral Streptococci, Cytokines, PAF-r in EC Coagulation
The Effects of Teenage and Illegitimate Births
Recently added grants:
Integrating a combination HIV prevention intervention into a widely-used geosocial app for Chinese MSM
Targeting intestinal vitamin D receptor signaling to mitigate graft-versus-host disease
The Role of Casual Contact and Migration in XDR TB Transmission in South Africa: a Geospatial, Genomic and Social Network Study
Discovery and preclinical evaluation of Plasmodium falciparum and P. vivax coiled coil antigens for malaria vaccine development
Vaccine-mediated control of bacterial virulence regulation and infection
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM007361-000
Application #
3608305
Study Section
Project Start
1990-09-28
Project End
Budget Start
1990-09-28
Budget End
1991-03-27
Support Year
Fiscal Year
1990
Total Cost
Indirect Cost
Institution
Name
Hipple Cancer Research Corporation
Department
Type
DUNS #
City
Dayton
State
OH
Country
United States
Zip Code
45439
Publications
Erickson-Miller, C L; May, R D; Tomaszewski, J et al.
(1997)
Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro.
Cancer Chemother Pharmacol 39:467-72
Comments
Be the first to comment on Martin Murphy's grant